Vietnam Pharmaceutical Standard Report Q1/2020
VIETNAM PHARMACEUTICAL INDUSTRY
The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018.
By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 - 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,
The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018.
By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 - 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,
Abbreviations
Report summary
1. BUSINESS ENVIRONMENT
1.1. Macroeconomic situation
1.2. Legal framework
2. PHARMACEUTICAL INDUSTRY OVERVIEW
2.1. Global Pharmaceutical Industry
2.1.1. Production - Consumption
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Production
2.2.6. Consumption
2.2.7. Export - Import
2.2.8. Price movements
2.3. Industry planning
2.4. Driving forces and forecast
3. ENTERPRISE ANALYSIS
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
Report summary
1. BUSINESS ENVIRONMENT
1.1. Macroeconomic situation
1.2. Legal framework
2. PHARMACEUTICAL INDUSTRY OVERVIEW
2.1. Global Pharmaceutical Industry
2.1.1. Production - Consumption
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Production
2.2.6. Consumption
2.2.7. Export - Import
2.2.8. Price movements
2.3. Industry planning
2.4. Driving forces and forecast
3. ENTERPRISE ANALYSIS
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
LIST OF FIGURES
Figure 1: Share of healthy sector and social assistance activities in total GDP, 2010-2019
Figure 2: Consumer price index of drug and medical service, 2012 - 2019
Figure 3: Population and population growth, 2010 - 2019
Figure 4: VND/USD exchange rate, 1/2013 - 12/2019
Figure 5: VND/CNY exchange rate, 1/2016 – 12/2019
Figure 7: Quantity of new drugs licensed by FDA, 2010 - 2019
Figure 8: World E&D investment costs, 2010-2024f
Figure 9: Top 10 enterprises with the largest R&D costs, 2018
Figure 10: Top 10 enterprises with the largest R&D costs, 2024
Figure 11: Revenue of the global pharmaceutical industry, 2010 - 2019e
Figure 12: Degree of risk from loss of patent protection, 2012-2019e
Figure 14: World sales of prescription and generic drug, 2010-2019e
Figure 13: Share of pharmaceutical sales by technology, 2010-2019e
Figure 15: Pharmaceutical consumption market share by group, 2018
Figure 16: Spending on medicines by treatment area, 2018
Figure 17: Average capital, fixed assets and long-term average investment of enterprises, 2010 - 2018
Figure 18: Number of enterprises and workers in medicine, chemical and pharmaceutical manufacturing sectors, 2010 - 2018
Figure 19: Net Revenue and profit before tax, 2010 - 2018
Figure 20: Domestic pharmaceutical production value, 2010 - 2019e
Figure 21: The market value of pharmaceutical industry, 2013 - 2019e
Figure 22: Value ratio of domestically produced medicines in Vietnam, 2010 – 2019e
Figure 23: Domestically produced medicine consumption, 2010 – 2019e
Figure 24: Spending on medicines in Vietnam, 2009 – 2019e
Figure 25: Spending on medicines per capita in some countries, 2018e
Figure 26: Structure of drug consumption by channel, 2013- 2019e
Figure 27: Situation of patented and generic drugs, 2013-2019e
Figure 29: Market value of prescription drugs (ETC), 2011 – 2019e
Figure 30: Over-the-counter (OTC) market, 2013 - 2019e
Figure 31: OTC market share by sales channel, 2019e
Figure 32: Patented drugs (Patent), 2010 – 2019e
Figure 33: Generic drug market, 2013 – 2019e
Figure 34: Import of pharmaceutical products from a number of countries, 2018 - 2019e
Figure 35: Import of pharmaceutical products from India, 2013 – 2019e
Figure 36: Pharmaceutical exports, 2012-2019e
Figure 37: Top major exporting countries, 2019
Figure 38: M&A of pharmaceutical industry, 2010-2019
Figure 39: Sales of prescription drug, 2017-2024f
Figure 40: Prescription drug sales of the top 10 largest companies, 2024f
Figure 41: Drug manufacturing by technology,2017-2024f
Figure 42: Growth of total drug consumption value in Vietnam, 2013-2013f
Figure 43: Median drug spending per capita, 2017-2023f
Figure 44: DHG shareholder structure, 2018
Figure 45: TRA shareholder structure, 2018
Figure 46: DMC shareholder structure, 2018
Figure 47: Imexpharm shareholder structure, 2018
Figure 48: OPC shareholder structure, 2018
Figure 49: SPM shareholder structure, 2018
Figure 50: Vimedimex shareholder structure, 2018
Figure 51: DHT shareholder structure, 2018
Figure 52: DBT shareholder structure, 2018
Figure 53: LDP shareholder structure, 2018
Figure 54: Gross profit margin, 2017 - 2018
Figure 55: Selling expenses, 2017-2018
Figure 56: General and administrative expenses, 2017-2018
Figure 57: Number of inventory days, 2018
Figure 58: Average payment period, 2018
Figure 59: Payment index, 2017-2018
Figure 60: Profit ratio, 2017 - 2018
Figure 1: Share of healthy sector and social assistance activities in total GDP, 2010-2019
Figure 2: Consumer price index of drug and medical service, 2012 - 2019
Figure 3: Population and population growth, 2010 - 2019
Figure 4: VND/USD exchange rate, 1/2013 - 12/2019
Figure 5: VND/CNY exchange rate, 1/2016 – 12/2019
Figure 7: Quantity of new drugs licensed by FDA, 2010 - 2019
Figure 8: World E&D investment costs, 2010-2024f
Figure 9: Top 10 enterprises with the largest R&D costs, 2018
Figure 10: Top 10 enterprises with the largest R&D costs, 2024
Figure 11: Revenue of the global pharmaceutical industry, 2010 - 2019e
Figure 12: Degree of risk from loss of patent protection, 2012-2019e
Figure 14: World sales of prescription and generic drug, 2010-2019e
Figure 13: Share of pharmaceutical sales by technology, 2010-2019e
Figure 15: Pharmaceutical consumption market share by group, 2018
Figure 16: Spending on medicines by treatment area, 2018
Figure 17: Average capital, fixed assets and long-term average investment of enterprises, 2010 - 2018
Figure 18: Number of enterprises and workers in medicine, chemical and pharmaceutical manufacturing sectors, 2010 - 2018
Figure 19: Net Revenue and profit before tax, 2010 - 2018
Figure 20: Domestic pharmaceutical production value, 2010 - 2019e
Figure 21: The market value of pharmaceutical industry, 2013 - 2019e
Figure 22: Value ratio of domestically produced medicines in Vietnam, 2010 – 2019e
Figure 23: Domestically produced medicine consumption, 2010 – 2019e
Figure 24: Spending on medicines in Vietnam, 2009 – 2019e
Figure 25: Spending on medicines per capita in some countries, 2018e
Figure 26: Structure of drug consumption by channel, 2013- 2019e
Figure 27: Situation of patented and generic drugs, 2013-2019e
Figure 29: Market value of prescription drugs (ETC), 2011 – 2019e
Figure 30: Over-the-counter (OTC) market, 2013 - 2019e
Figure 31: OTC market share by sales channel, 2019e
Figure 32: Patented drugs (Patent), 2010 – 2019e
Figure 33: Generic drug market, 2013 – 2019e
Figure 34: Import of pharmaceutical products from a number of countries, 2018 - 2019e
Figure 35: Import of pharmaceutical products from India, 2013 – 2019e
Figure 36: Pharmaceutical exports, 2012-2019e
Figure 37: Top major exporting countries, 2019
Figure 38: M&A of pharmaceutical industry, 2010-2019
Figure 39: Sales of prescription drug, 2017-2024f
Figure 40: Prescription drug sales of the top 10 largest companies, 2024f
Figure 41: Drug manufacturing by technology,2017-2024f
Figure 42: Growth of total drug consumption value in Vietnam, 2013-2013f
Figure 43: Median drug spending per capita, 2017-2023f
Figure 44: DHG shareholder structure, 2018
Figure 45: TRA shareholder structure, 2018
Figure 46: DMC shareholder structure, 2018
Figure 47: Imexpharm shareholder structure, 2018
Figure 48: OPC shareholder structure, 2018
Figure 49: SPM shareholder structure, 2018
Figure 50: Vimedimex shareholder structure, 2018
Figure 51: DHT shareholder structure, 2018
Figure 52: DBT shareholder structure, 2018
Figure 53: LDP shareholder structure, 2018
Figure 54: Gross profit margin, 2017 - 2018
Figure 55: Selling expenses, 2017-2018
Figure 56: General and administrative expenses, 2017-2018
Figure 57: Number of inventory days, 2018
Figure 58: Average payment period, 2018
Figure 59: Payment index, 2017-2018
Figure 60: Profit ratio, 2017 - 2018
LIST OF TABLES
Table 1: Statistics of drug production by category, 2013 –2018e
Table 2: Vietnam’s top import partners, 2018
Table 3: Top exporting enterprises, 2018
Table 4: Price movements of some major drugs in the market, 12/2017 – 12/2018
Table 5: The difference in the price of some drugs at some drug stores, 2017
Table 6: The number of medical facilities, 2010 - 2016
Table 7: 10 typical pharmaceutical enterprises in 2017
Table 1: Statistics of drug production by category, 2013 –2018e
Table 2: Vietnam’s top import partners, 2018
Table 3: Top exporting enterprises, 2018
Table 4: Price movements of some major drugs in the market, 12/2017 – 12/2018
Table 5: The difference in the price of some drugs at some drug stores, 2017
Table 6: The number of medical facilities, 2010 - 2016
Table 7: 10 typical pharmaceutical enterprises in 2017
